Monalizumab: all 21 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2Not yet recruitingNCT07146230Phase 2
- Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical TransplantationRecruitingNCT06892223Phase 2
- A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder CancerRecruitingNCT06503614Phase 2
- MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung CancerRecruitingNCT05903092Phase 2
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerRecruitingNCT05061550Phase 2
- Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck CancerActive, not recruitingNCT04590963Phase 3Results posted
- Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLCCompletedNCT03822351Phase 2Results posted
- Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 TrialCompletedNCT03801902Phase 1Results posted
- Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLLTerminatedNCT02557516Phase 1/2Results posted
- Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic CancerWithdrawnNCT06152523Phase 2
- A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerActive, not recruitingNCT05221840Phase 3
- Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 InfectionCompletedNCT04333914Phase 2
- Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trialCompletedNCT04307329Phase 2
- Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI ResistanceActive, not recruitingNCT03833440Phase 2
- Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CAWithdrawnNCT03307941Phase 1/2
- Biomarker-based Study in R/M SCCHNActive, not recruitingNCT03088059Phase 2
- Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell TransplantationStatus unknownNCT02921685Phase 1
- Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02643550Phase 1/2
- A Dose-Ranging Study of IPH2201 in Patients With Gynecologic MalignanciesCompletedNCT02459301Phase 1
- Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral CavityTerminatedNCT02331875Phase 1/2
- Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid ArthritisCompletedNCT01370902Phase 1